TNF-α in Tuberculosis: A Cytokine with a Split Personality
暂无分享,去创建一个
[1] A. Mantovani,et al. Role of the chemokine decoy receptor D6 in balancing inflammation, immune activation, and antimicrobial resistance in Mycobacterium tuberculosis infection , 2008, The Journal of experimental medicine.
[2] D. Kirschner,et al. Tumor Necrosis Factor Blockade in Chronic Murine Tuberculosis Enhances Granulomatous Inflammation and Disorganizes Granulomas in the Lungs , 2008, Infection and Immunity.
[3] Akira Yamamoto,et al. Creation and X-ray Structure Analysis of the Tumor Necrosis Factor Receptor-1-selective Mutant of a Tumor Necrosis Factor-α Antagonist* , 2008, Journal of Biological Chemistry.
[4] R. Wilkinson,et al. Reduction of Chemokine Secretion in Response to Mycobacteria in Infliximab-Treated Patients , 2007, Clinical and Vaccine Immunology.
[5] R. Appelberg,et al. Characterization of the Deregulated Immune Activation Occurring at Late Stages of Mycobacterial Infection in TNF-Deficient Mice1 , 2007, The Journal of Immunology.
[6] B. Ryffel,et al. Dominant-Negative Inhibitors of Soluble TNF Attenuate Experimental Arthritis without Suppressing Innate Immunity to Infection , 2007, The Journal of Immunology.
[7] K. Oguchi,et al. TNF-α Drives Human CD14+ Monocytes to Differentiate into CD70+ Dendritic Cells Evoking Th1 and Th17 Responses , 2007, The Journal of Immunology.
[8] J. Flynn,et al. Tumor necrosis factor and tuberculosis. , 2007, The journal of investigative dermatology. Symposium proceedings.
[9] J. Pieters,et al. Interaction of pathogenic mycobacteria with the host immune system. , 2006, Current opinion in microbiology.
[10] Jean-Louis Herrmann,et al. DC-SIGN Induction in Alveolar Macrophages Defines Privileged Target Host Cells for Mycobacteria in Patients with Tuberculosis , 2005, PLoS medicine.
[11] Jun Wang,et al. Small-Molecule Inhibition of TNF-α , 2005, Science.
[12] S. Stenger. Immunological control of tuberculosis: role of tumour necrosis factor and more , 2005, Annals of the rheumatic diseases.
[13] Warwick J. Britton,et al. Transmembrane TNF Is Sufficient to Initiate Cell Migration and Granuloma Formation and Provide Acute, but Not Long-Term, Control of Mycobacterium tuberculosis Infection1 , 2005, The Journal of Immunology.
[14] J. Ficker,et al. Inverse Correlation of Maturity and Antibacterial Activity in Human Dendritic Cells1 , 2005, The Journal of Immunology.
[15] J. Ellner,et al. Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda. , 2005, The Journal of infectious diseases.
[16] Silvano Sozzani,et al. The chemokine system in diverse forms of macrophage activation and polarization. , 2004, Trends in immunology.
[17] J. Flynn,et al. CCR5-Deficient Mice Control Mycobacterium tuberculosis Infection despite Increased Pulmonary Lymphocytic Infiltration1 , 2004, The Journal of Immunology.
[18] Simeone Marino,et al. Dendritic Cell Trafficking and Antigen Presentation in the Human Immune Response to Mycobacterium tuberculosis 1 , 2004, The Journal of Immunology.
[19] M. Rojas,et al. Differential induction of apoptosis and necrosis in monocytes from patients with tuberculosis and healthy control subjects. , 2004, The Journal of infectious diseases.
[20] R S Wallis,et al. Granulomatous infectious diseases associated with tumor necrosis factor antagonists. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] A. Sher,et al. MyD88-Deficient Mice Display a Profound Loss in Resistance to Mycobacterium tuberculosis Associated with Partially Impaired Th1 Cytokine and Nitric Oxide Synthase 2 Expression , 2004, Infection and Immunity.
[22] S. Hickman,et al. Cutting Edge: A New Approach to Modeling Early Lung Immunity in Murine Tuberculosis1 , 2004, The Journal of Immunology.
[23] B. Gicquel,et al. TNF-alpha is a critical negative regulator of type 1 immune activation during intracellular bacterial infection. , 2004, The Journal of clinical investigation.
[24] John L. Johnson,et al. A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis , 2004, AIDS.
[25] J. Flynn,et al. In Situ Studyof Abundant Expression of Proinflammatory Chemokines and Cytokines inPulmonary Granulomas That Develop in Cynomolgus MacaquesExperimentally Infected with Mycobacteriumtuberculosis , 2003, Infection and Immunity.
[26] J. Flynn,et al. Chemokines and tuberculosis. , 2003, Cytokine & growth factor reviews.
[27] S. Ehlers,et al. Role of tumour necrosis factor (TNF) in host defence against tuberculosis: implications for immunotherapies targeting TNF , 2003, Annals of the rheumatic diseases.
[28] Eugene A Zhukovsky,et al. Inactivation of TNF Signaling by Rationally Designed Dominant-Negative TNF Variants , 2003, Science.
[29] S. Kaufmann,et al. Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis , 2003, Nature Medicine.
[30] P. Haslett,et al. Mycobacterium tuberculosis inhibits maturation of human monocyte-derived dendritic cells in vitro. , 2003, The Journal of infectious diseases.
[31] R. Long,et al. Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. , 2003, The Lancet. Infectious diseases.
[32] J. Ernst,et al. Mechanisms of cell recruitment in the immune response to Mycobacterium tuberculosis. , 2003, Microbes and infection.
[33] T. Geijtenbeek,et al. Mycobacteria Target DC-SIGN to Suppress Dendritic Cell Function , 2003, The Journal of experimental medicine.
[34] P. Selby,et al. Mycobacterium bovis bacillus Calmette–Guérin‐infected dendritic cells potently activate autologous T cells via a B7 and interleukin‐12‐dependent mechanism , 2003, Immunology.
[35] B. Samten,et al. Serum cytokine concentrations do not parallel Mycobacterium tuberculosis-induced cytokine production in patients with tuberculosis. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[36] S. Kaufmann,et al. Protection against tuberculosis: cytokines, T cells, and macrophages , 2002, Annals of the rheumatic diseases.
[37] N. Reiling,et al. Cutting Edge: Toll-Like Receptor (TLR)2- and TLR4-Mediated Pathogen Recognition in Resistance to Airborne Infection with Mycobacterium tuberculosis1 , 2002, The Journal of Immunology.
[38] B. Ryffel,et al. Toll-Like Receptor 4 Expression Is Required to Control Chronic Mycobacterium tuberculosis Infection in Mice1 , 2002, The Journal of Immunology.
[39] D. Goeddel,et al. TNF-R1 Signaling: A Beautiful Pathway , 2002, Science.
[40] Xiao-Yu Song,et al. Binding and functional comparisons of two types of tumor necrosis factor antagonists. , 2002, The Journal of pharmacology and experimental therapeutics.
[41] Andrew G. D. Bean,et al. TNF Regulates Chemokine Induction Essential for Cell Recruitment, Granuloma Formation, and Clearance of Mycobacterial Infection1 , 2002, The Journal of Immunology.
[42] R. Strieter,et al. β-Chemokines Are Induced by Mycobacterium tuberculosis and Inhibit Its Growth , 2002, Infection and Immunity.
[43] S. Akira,et al. [Induction of direct antimicrobial activity through mammalian toll-like receptors]. , 2001, Pneumologie.
[44] J. Flynn,et al. Immunology of tuberculosis. , 2003, Annual review of immunology.
[45] J. Lafitte,et al. Expression of IFN-gamma-inducible protein; monocyte chemotactic proteins 1, 3, and 4; and eotaxin in TH1- and TH2-mediated lung diseases. , 2001, The Journal of allergy and clinical immunology.
[46] P. Holt. Antigen presentation in the lung. , 2000, American journal of respiratory and critical care medicine.
[47] R M Siegel,et al. A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. , 2000, Science.
[48] P. Bardin,et al. In Situ Production of Gamma Interferon, Interleukin-4, and Tumor Necrosis Factor Alpha mRNA in Human Lung Tuberculous Granulomas , 2000, Infection and Immunity.
[49] B. Ryffel,et al. Fatal Mycobacterium bovis BCG infection in TNF-LT-α-deficient mice , 2000 .
[50] Z. Toossi. The inflammatory response in Mycobacterium tuberculosis infection. , 2000, Archivum immunologiae et therapiae experimentalis.
[51] C Caux,et al. Immunobiology of dendritic cells. , 2000, Annual review of immunology.
[52] A. Aderem,et al. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[53] J. Keane,et al. Macrophage apoptosis in mycobacterial infections , 1999, Journal of leukocyte biology.
[54] J. Friedland,et al. Pulmonary epithelial cells are a source of IL-8 in the response to Mycobacterium tuberculosis: essential role of IL-1 from infected monocytes in a NF-kappa B-dependent network. , 1999, Journal of immunology.
[55] K. Pfeffer,et al. Fatal Granuloma Necrosis without Exacerbated Mycobacterial Growth in Tumor Necrosis Factor Receptor p55 Gene-Deficient Mice Intravenously Infected with Mycobacterium avium , 1999, Infection and Immunity.
[56] A. Mantovani,et al. The chemokine system: redundancy for robust outputs. , 1999, Immunology today.
[57] M. Olivier,et al. TNF-alpha and IL-10 modulate the induction of apoptosis by virulent Mycobacterium tuberculosis in murine macrophages. , 1999, Journal of immunology.
[58] F. Luscinskas,et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions , 1999, Nature.
[59] Q. Hamid,et al. The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. , 1999, Journal of immunology.
[60] Jason G. Cyster,et al. Chemokines and the Homing of Dendritic Cells to the T Cell Areas of Lymphoid Organs , 1999, The Journal of experimental medicine.
[61] R. Steinman,et al. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. , 1998, Science.
[62] T. Ganz,et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. , 1998, Science.
[63] Christoph Schaniel,et al. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation , 1998, European journal of immunology.
[64] Z. Toossi,et al. Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis. , 1998, American journal of respiratory cell and molecular biology.
[65] R Bonecchi,et al. Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. , 1998, Journal of immunology.
[66] H. Macdonald,et al. Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. , 1998, Journal of immunology.
[67] P. Barnes,et al. Production of Monocyte Chemoattractant Protein 1 in Tuberculosis Patients , 1998, Infection and Immunity.
[68] J. Ellner,et al. Expression of Virulence of Mycobacterium tuberculosiswithin Human Monocytes: Virulence Correlates with Intracellular Growth and Induction of Tumor Necrosis Factor Alpha but Not with Evasion of Lymphocyte-Dependent Monocyte Effector Functions , 1998, Infection and Immunity.
[69] M. Torres,et al. Cytokine Profiles for Peripheral Blood Lymphocytes from Patients with Active Pulmonary Tuberculosis and Healthy Household Contacts in Response to the 30-Kilodalton Antigen ofMycobacterium tuberculosis , 1998, Infection and Immunity.
[70] M. Burdick,et al. Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis , 1997, Infection and immunity.
[71] A. Kharazmi,et al. Interferon‐γ Production by Human T Cells and Natural Killer Cells In Vitro in Response to Antigens from the Two Intracellular Pathogens Mycobacterium tuberculosis and Leishmania major , 1997, Scandinavian journal of immunology.
[72] T. Byrd. Tumor necrosis factor alpha (TNFalpha) promotes growth of virulent Mycobacterium tuberculosis in human monocytes iron-mediated growth suppression is correlated with decreased release of TNFalpha from iron-treated infected monocytes. , 1997, The Journal of clinical investigation.
[73] R. Arbeit,et al. Programmed cell death of Mycobacterium avium serovar 4-infected human macrophages prevents the mycobacteria from spreading and induces mycobacterial growth inhibition by freshly added, uninfected macrophages. , 1997, Journal of immunology.
[74] N. Mukaida,et al. Elevated chemokine levels in bronchoalveolar lavage fluid of tuberculosis patients. , 1997, American journal of respiratory and critical care medicine.
[75] Nicole Nelson,et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells , 1997, Nature.
[76] F. Sallusto,et al. Origin, maturation and antigen presenting function of dendritic cells. , 1997, Current opinion in immunology.
[77] P. Holt,et al. Brief Definitive Report Dendritic Cells Are Recruited into the Airway Epithelium during the Inflammatory Response to a Broad Spectrum of Stimuli , 2022 .
[78] L. Culp,et al. Induction of monocyte expression of tumor necrosis factor alpha by the 30-kD alpha antigen of Mycobacterium tuberculosis and synergism with fibronectin. , 1996, The Journal of clinical investigation.
[79] Z. Toossi. Cytokine circuits in tuberculosis. , 1996, Infectious agents and disease.
[80] G. Rook,et al. The pathogenesis of tuberculosis. , 1996, Annual review of microbiology.
[81] C. Lowenstein,et al. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. , 1995, Immunity.
[82] H. Shiratsuchi,et al. Enhanced production of TGF-beta by blood monocytes from patients with active tuberculosis and presence of TGF-beta in tuberculous granulomatous lung lesions. , 1995, Journal of immunology.
[83] Z. Toossi,et al. Enhancement of intracellular growth of Mycobacterium tuberculosis in human monocytes by transforming growth factor-beta 1. , 1994, The Journal of infectious diseases.
[84] G. Kaplan,et al. Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guerin , 1994, The Journal of experimental medicine.
[85] S. Carsons,et al. Mechanisms of tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-induced dendritic cell development. , 1993, Blood.
[86] G. Rook,et al. The effect of Mycobacterium tuberculosis on the susceptibility of human cells to the stimulatory and toxic effects of tumour necrosis factor. , 1992, Immunology.
[87] S. Carsons,et al. TNF in combination with GM‐CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages , 1992, Journal of leukocyte biology.
[88] J. Abrams,et al. Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure. , 1992, Journal of immunology.
[89] B. Bloom,et al. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages , 1992, The Journal of experimental medicine.
[90] G. Rook,et al. Effect of mycobacteria on sensitivity to the cytotoxic effects of tumor necrosis factor , 1991, Infection and immunity.
[91] S. Sprang. The divergent receptors for TNF. , 1990, Trends in biochemical sciences.
[92] V. Kindler,et al. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection , 1989, Cell.
[93] D. Brenner,et al. Prolonged activation of jun and collagenase genes by tumour necrosis factor-α , 1989, Nature.
[94] J. Ellner,et al. Expression of tumor necrosis factor in vitro by human mononuclear phagocytes stimulated with whole Mycobacterium bovis BCG and mycobacterial antigens , 1988, Infection and immunity.
[95] D. Brenner,et al. Tumor necrosis factor alpha inhibits collagen gene transcription and collagen synthesis in cultured human fibroblasts. , 1988, The Journal of biological chemistry.
[96] C. Perez,et al. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: Ramifications for the complex physiology of TNF , 1988, Cell.
[97] M. Kaliner,et al. Dendritic cells with antigen-presenting capability reside in airway epithelium, lung parenchyma, and visceral pleura , 1986, The Journal of experimental medicine.
[98] Bharat B. Aggarwal,et al. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin , 1984, Nature.
[99] R L Kassel,et al. An endotoxin-induced serum factor that causes necrosis of tumors. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[100] G. Granger,et al. Lymphocyte in vitro Cytotoxicity: Specific Release of Lymphotoxin-like Materials from Tuberculin-sensitive Lymphoid Cells , 1969, Nature.